Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors

Activation of the PI3K/AKT pathway occurs in the vast majority of advanced prostate cancers (PCas). Activation of fibroblast growth factor receptor (FGFR) signaling occurs in a wide variety of malignancies, including PCa. RNA-Seq of castration resistant PCa revealed expression of multiple FGFR signa...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Shu, Shao, Longjiang, Castro, Patricia, Coleman, Ilsa, Nelson, Peter S, Smith, Paul D, Davies, Barry R, Ittmann, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351622/
https://www.ncbi.nlm.nih.gov/pubmed/28008155
http://dx.doi.org/10.18632/oncotarget.14049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351622/
https://www.ncbi.nlm.nih.gov/pubmed/28008155
http://dx.doi.org/10.18632/oncotarget.14049

Ejemplares similares